Shattuck Labs Announces Participation in Upcoming BTIG Virtual Biotechnology Conference

Presentation Details Conference: BTIG Virtual Biotechnology Conference Format: Fireside chat with covering analyst, Kaveri Pohlman, Ph.D. Presenter: Dr. Taylor Schreiber, M.D., Ph.D., Shattuck's Chief Executive Officer Date: August 5, 2024 Time: 2:00 p.m. ET Shattuck Labs, Inc. (Nasdaq: STTK) is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Compounds deri ...